Catalyst Bioscieences
Crescent Biopharma, Inc., a biotech firm innovating cancer therapies, develops CR‑001, a bispecific anti‑PD‑1/anti‑VEGF antibody for solid tumors, alongside CR‑002 and CR‑003, with partnerships to advance oncology therapeutics in the U.S.
Headquarters: United States (USA)
- Website: Visit Site 🔗
- Type: Corporation
Company Profile
- Sector: Manufacturing
- Industry: Pharmaceutical Manufacturing
- Employees: 41
- HQ: Waltham
Unlock the full potential.
Upgrade
Get access to Relative P/E Ratio Valuation Histogram.